The BSI is one of the oldest, largest, and most operative, Immunology societies in the world and is the largest in Europe. Our members are based all over the world, admist the majority working in Britain.
The BSI’s main objective is to promote and support virtue in research, scholarship and clinical practice in immunology for the benefit of human and animal health and welfare. The BSI seeks to avail British Immunology accomplish the highest possible goals. To meet this objective, the BSI undertakes the following:
- Running innovative events in research, public engagement and education
- Promoting and disseminating research and good practice in Immunology, translational medicine and vaccination
- Working with its members to develop the assistance of membership and the relevance of the Society
- Providing bursaries and grants
- Enhancing public awareness of immunology
- Influencing policy and decision makers
- Working with other societies
- Market Capitalization of Immunological companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric relapse. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their accomplishment.
The following is the list of scholars from British Society for Immunology who contributed and/or serves as editors for one or more OMICS International journals and conferences